1. Effectiveness of perioperative remimazolam in preventing postoperative delirium: a systematic review and meta-analysis
- Author
-
Mingzhen Wang, Jinhui Liu, Wenjie Liu, Xin Zhang, Gaofeng Zhang, Lixin Sun, Yanlin Bi, Hong Wang, and Rui Dong
- Subjects
Postoperative delirium ,Remimazolam ,General anesthesia ,Safety ,Meta-analysis ,Medicine - Abstract
Abstract Background To compare the POD rates in patients undergoing non-cardiac surgery who received remimazolam perioperatively versus placebo or other sedatives. Methods We systematically searched four major databases (Cochrane Central Register of Controlled Trials, Web of Science, Embase, and PubMed) for relevant randomized controlled trials (RCTs) up to July 11, 2024. Literature quality evaluation was used the bias risk table in Review Manager 5.4. The primary outcome of interest was POD, and secondary outcomes were the hypotension risk, bradycardia and, nausea and vomiting. Results Across 11 trials involving 1985 participants, we recorded 309 cases of POD during follow-up. In trials where the control group received saline, remimazolam decrease the risk of POD significantly by 70% (RR 0.30, 95% CI [0.19, 0.46]; p
- Published
- 2025
- Full Text
- View/download PDF